Your browser doesn't support javascript.
loading
VaNoLaH trial: a study protocol-a multinational randomised controlled trial including two identical substudies comparing vaginal versus vNOTES (vaginal natural orifice transluminal surgery) hysterectomy or laparoscopic versus vNOTES hysterectomy.
Baekelandt, Jan Filip; Stuart, Andrea; Wagenius, Johanna; Laenen, Annouschka; Mol, Ben W; Deprest, Jan; Bosteels, Jan J A.
Afiliación
  • Baekelandt JF; Imeldaziekenhuis, Bonheiden, Belgium.
  • Stuart A; Obstetrics and Gynecology, Lund University Department of Clinical Sciences Lund, Lund, Sweden andrea.stuart@med.lu.se.
  • Wagenius J; Department of Obstetrics and Gynecology, Helsingborg, Sweden.
  • Laenen A; Obstetrics and Gynecology, Lund University Department of Clinical Sciences Lund, Lund, Sweden.
  • Mol BW; Department of Obstetrics and Gynecology, Helsingborg, Sweden.
  • Deprest J; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.
  • Bosteels JJA; OB/GYN, School of Medicine, Monash University, Melbourne, Clayton, Victoria, Australia.
BMJ Open ; 14(4): e081979, 2024 Apr 23.
Article en En | MEDLINE | ID: mdl-38658010
ABSTRACT

INTRODUCTION:

Hysterectomy is one of the most common surgeries performed in women. Minimally invasive methods are on the rise globally as they have been shown to decrease surgical morbidity compared with abdominal hysterectomy. Hysterectomy by vaginal natural orifice transluminal endoscopic surgery (vNOTES) is the latest innovation. It combines the vaginal approach and endoscopy via the vagina. Large pragmatic randomised controlled trials (RCTs) are lacking comparing outcomes after vNOTES, vaginal hysterectomy (VH) and laparoscopic hysterectomy (LH).

METHODS:

Multicentre pragmatic RCT aiming to recruit 1000 women aged 18-75 years undergoing hysterectomy for benign disease. The RCT includes two identical substudies (groups A and B). If VH is considered safe and feasible, the patient will be randomised within group A (VH vs vNOTES). If VH is not considered safe or feasible, patients will be randomised within group B (LH vs vNOTES).

ANALYSIS:

Primary outcome is the proportion of women leaving the hospital within 12 hours after surgery. Secondary outcomes are hospitalisation time, conversion rates, duration of the surgical procedure, intraoperative complications, postoperative complications and readmission. ETHICS AND DISSEMINATION The Ethical Board Committee at Imelda Hospital, Bonheiden, Belgium, has approved the research protocol 230704 (principal investigator). Before including patients, all centres will require local or national ethical approval. The results of the study will be published in international peer-reviewed journals. TRIAL REGISTRATION NUMBER NCT05971875.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Laparoscopía / Cirugía Endoscópica por Orificios Naturales / Histerectomía Vaginal Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: BMJ Open Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Laparoscopía / Cirugía Endoscópica por Orificios Naturales / Histerectomía Vaginal Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: BMJ Open Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido